Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01708408 · ClinicalTrials.gov registry record

The MURDOCK Study Registry and Biorepository Horizon 1.5

A clinical trial of Healthy Volunteers and Chronic Disease, sponsored by Duke University.

Active
Registry status
50,000
Enrollment target
1
Study location

NCT01708408 is a study of Healthy Volunteers and Chronic Disease that is active but no longer recruiting, run by Duke University. The registered enrollment target is 50,000 participants, above the 305-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (16293% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01708408, a study of Healthy Volunteers and Chronic Disease, is active but no longer recruiting, sponsored by Duke University.

ACTIVE NOT RECRUITING
Registry status
50,000 participants
Enrollment target
1
Study location

Study Summary

The MURDOCK Study Community Registry and Biorepository (Horizon 1.5) aims to create a large-scale community registry and biorepository that can be used as a vehicle for future health services, epidemiologic, clinical trials and other omics-related research.

Interventions

  • GENETIC Biomarker studies

Study Locations (1)

North Carolina

  • Duke Clinical Translational Science Institute-MURDOCK Study - Kannapolis

Trial Details

FieldValue
Enrollment Target 50,000 participants
Start Date 2009-02
Est. Completion 2026-12

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT01708408

The ClinicalTrials.gov registry entry for NCT01708408 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 50,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 305-participant average among 283 other Healthy Volunteers trials with a reported enrollment target (16293% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Healthy Volunteers appearing as the primary indexed condition, and to 1 intervention - of which Biomarker studies is the first listed.

NCT01708408 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT01708408 about?

NCT01708408 is a clinical study titled "The MURDOCK Study Registry and Biorepository Horizon 1.5". The MURDOCK Study Community Registry and Biorepository (Horizon 1.5) aims to create a large-scale community registry and biorepository that can be used as a vehicle for future health services, epidemiologic, clinical trials and other omics-related research.

What is the current status of trial NCT01708408?

This trial is currently active not recruiting. The enrollment target is 50,000 participants. The study started on 2009-02. Estimated completion is 2026-12.

What conditions does trial NCT01708408 study?

This clinical trial studies the following conditions: Healthy Volunteers, Chronic Disease.

What interventions are being tested in trial NCT01708408?

The interventions under investigation include: Biomarker studies (GENETIC).

Who is sponsoring clinical trial NCT01708408?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01708408 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy Volunteers

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.